Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Total Debt (2022 - 2023)

Pasithea Therapeutics' (KTTAW) quarterly Total Debt came in at $133335.0 in Q2 2023, down 49.51% quarter-over-quarter from $264103.0 in Q1 2023.

Analysis

Pasithea Therapeutics Corp. (KTTAW) Total Debt (2022 - 2023) Analysis & Trends

Pasithea Therapeutics has disclosed Total Debt across 2 years of filings, most recently posting $133335.0 for Q2 2023.

  • In Q2 2023, Total Debt changed N/A year-over-year to $133335.0; the TTM figure through Jun 2023 stood at $133335.0 (changed N/A YoY), while the FY2022 annual figure was $8611.0, changed N/A from the prior year.
  • Total Debt came in at $133335.0 for Q2 2023 at Pasithea Therapeutics, down from $264103.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $264103.0 in Q1 2023 to a low of $8611.0 in Q4 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 133,335.00
Mar 31, 2023 264,103.00
Dec 31, 2022 8,611.00